Amlodipine Besylate; Atorvastatin Calcium Patent Expiration
Amlodipine Besylate; Atorvastatin Calcium is used for treating hypercholesterolemia, hyperlipidemia, and hypertension. It was first introduced by Pharmacia And Upjohn Co Llc
Amlodipine Besylate; Atorvastatin Calcium Patents
Given below is the list of patents protecting Amlodipine Besylate; Atorvastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Caduet | US6455574 | Therapeutic combination |
Aug 11, 2018
(Expired) | Pharmacia |
Caduet |
US5969156 (Pediatric) | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Jan 08, 2017
(Expired) | Pharmacia |
Caduet | US5969156 | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Jul 08, 2016
(Expired) | Pharmacia |
Caduet |
US5686104 (Pediatric) | Stable oral CI-981 formulation and process of preparing same |
May 11, 2015
(Expired) | Pharmacia |
Caduet | US5686104 | Stable oral CI-981 formulation and process of preparing same |
Nov 11, 2014
(Expired) | Pharmacia |
Caduet |
US6126971 (Pediatric) | Stable oral CI-981 formulation and process for preparing same |
Jul 19, 2013
(Expired) | Pharmacia |
Caduet | US6126971 | Stable oral CI-981 formulation and process for preparing same |
Jan 19, 2013
(Expired) | Pharmacia |
Amlodipine Besylate; Atorvastatin Calcium's Family Patents

Explore Our Curated Drug Screens
Amlodipine Besylate; Atorvastatin Calcium Generic API Manufacturers
Several generic applications have been filed for Amlodipine Besylate; Atorvastatin Calcium. The first generic version for Amlodipine Besylate; Atorvastatin Calcium was by Mylan Pharmaceuticals Inc and was approved on Nov 29, 2013. And the latest generic version is by Apotex Inc and was approved on Nov 18, 2019.
Given below is the list of companies who have filed for Amlodipine Besylate; Atorvastatin Calcium generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 8 different strengths of generic version for Amlodipine Besylate; Atorvastatin Calcium. All of these versions come by the name AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 5MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Nov 18, 2019 |
EQ 5MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Nov 18, 2019 |
EQ 5MG BASE; EQ 80MG BASE | tablet | Prescription | ORAL | AB | Nov 18, 2019 |
EQ 10MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Nov 18, 2019 |
EQ 10MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Nov 18, 2019 |
EQ 10MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Nov 18, 2019 |
EQ 10MG BASE; EQ 80MG BASE | tablet | Prescription | ORAL | AB | Nov 18, 2019 |
EQ 5MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Nov 18, 2019 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||
Canada |
| |||||||||||||
India |
|
2. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 11 different strengths of generic version for Amlodipine Besylate; Atorvastatin Calcium. All of these versions come by the name AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM. Given below are the details of the strengths of this generic introduced by Dr Reddys.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 10MG BASE; EQ 80MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 2.5MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 2.5MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 2.5MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 5MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 5MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 5MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 5MG BASE; EQ 80MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 10MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 10MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
EQ 10MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Mar 7, 2014 |
3. MYLAN
Mylan Pharmaceuticals Inc has filed for 11 different strengths of generic version for Amlodipine Besylate; Atorvastatin Calcium. All of these versions come by the name AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM. Given below are the details of the strengths of this generic introduced by Mylan.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 10MG BASE; EQ 80MG BASE | tablet | Prescription | ORAL | AB | Nov 29, 2013 |
EQ 2.5MG BASE; EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Nov 29, 2013 |
EQ 2.5MG BASE; EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Nov 29, 2013 |
EQ 2.5MG BASE; EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Nov 29, 2013 |
EQ 5MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Nov 29, 2013 |
EQ 5MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Nov 29, 2013 |
EQ 5MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Nov 29, 2013 |
EQ 5MG BASE; EQ 80MG BASE | tablet | Prescription | ORAL | AB | Nov 29, 2013 |
EQ 10MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Nov 29, 2013 |
EQ 10MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Nov 29, 2013 |
EQ 10MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Nov 29, 2013 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country | City | Firm Name | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||
India |
| |||||||||||||||||
Canada |
| |||||||||||||||||
Ireland |
|
4. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 11 different strengths of generic version for Amlodipine Besylate; Atorvastatin Calcium. All of these versions come by the name AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 10MG BASE; EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 2.5MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 5MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 5MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 5MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 5MG BASE; EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 10MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 10MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 10MG BASE; EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 2.5MG BASE; EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |
EQ 2.5MG BASE; EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jan 11, 2019 |